国产精品亚洲LV粉色,在电梯伦流澡到高潮H男男,久久久亚洲一区二区三区,国色天香A区与B区

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  關于我們  聯系我們
国产免费久久精品99久久,国产精品扒开腿做爽爽爽A片小说,99久久久无码国产精品不卡
首頁 > 產品中心 > 一抗 > 產品信息
ERVFRD-1 Rabbit pAb (bs-15466R)  
訂購熱線:400-901-9800
訂購郵箱:sales@www.hhi8.com
訂購QQ:  400-901-9800
技術支持:techsupport@www.hhi8.com
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包裝/詢價

產品編號 bs-15466R
英文名稱 ERVFRD-1 Rabbit pAb
中文名稱 ERVFRD-1抗體
別    名 SYCY2_HUMAN; EFRD1_HUMAN; Endogenous retrovirus group FRD member 1; Envelope polyprotein; HERV-FRD; HERV-FRD_6p24.1 provirus ancestral Env polyprotein; TM; SU; ERVFRD-1; ERVFRDE1; UNQ6191/PRO20218;  
Specific References  (2)     |     bs-15466R has been referenced in 2 publications.
[IF=5.168] Díaz-Carballo et al. Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells. (2017) Oncotarget. 8:95945-95964  other ;  Human.  
[IF=4.43] Díaz-Carballo, David, et al. "Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements." Journal of Experimental & Clinical Cancer Research 34.1 (2015): 81.  WB ;  Human.  
研究領域 細菌及病毒  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human
產品應用 WB=1:500-2000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 21/37/58 kDa
檢測分子量
細胞定位 細胞膜 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human HERV-FRD : 331-430/538 
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹 Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has retained its original fusogenic properties. Can make pseudotypes with MLV, HIV-1 or SIV-1 virions and confer infectivity.
SU mediates receptor recognition (By similarity).
TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane (By similarity).

Subunit:
The surface (SU) and transmembrane (TM) proteins form a heterodimer. SU and TM are attached by noncovalent interactions or by a labile interchain disulfide bond (By similarity).

Subcellular Location:
Virion.
Transmembrane protein: Cell membrane; Single-pass membrane protein (Potential).

Tissue Specificity:
Expressed at higher level in placenta. Expressed at lower level in adrenal, bone marrow, brain, breast, colon, kidney, lung, ovary, peripheral blood lymphocytes, prostate, skin, spleen, testis, thymus, thyroid, trachea.

Post-translational modifications:
Specific enzymatic cleavages in vivo yield the mature SU and TM proteins (By similarity).
The CXXC motif is highly conserved across a broad range of retroviral envelope proteins. It is thought to participate in the formation of a labile disulfide bond possibly with the CX6CC motif present in the transmembrane protein. Isomerization of the intersubunit disulfide bond to an SU intrachain disulfide bond is thought to occur upon receptor recognition in order to allow membrane fusion (By similarity).

Similarity:
Belongs to the gamma type-C retroviral envelope protein family. HERV class-I FRD env subfamily.

SWISS:
P60508

Gene ID:
405754

Database links:

SwissProt: P60508 Human



產品圖片
Sample: Lane 1: Human HeLa cell lysates Lane 2: Human HepG2 cell lysates Lane 3: Human A431 cell lysates Lane 4: Human SH-SY5Y cell lysates Lane 5: Human A549 cell lysates Lane 6: Human K562 cell lysates Lane 7: Human 293T cell lysates Primary: Anti-ERVF
版權所有 2004-2026 www.www.hhi8.com 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號